πŸ‡ΊπŸ‡Έ FDA
Patent

US 11385233

Methods of depleting malignant T-cells

granted A61KA61K31/00A61K40/11

Quick answer

US patent 11385233 (Methods of depleting malignant T-cells) held by AUTOLUS LIMITED expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AUTOLUS LIMITED
Grant date
Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/00, A61K40/11, A61K40/31, A61K40/421